Mergers and Aquisitions
The number of mergers and acquisitions in the pharmaceutical industry has continued to rise with each passing year. Of these deals, the largest proportion were for diversified assets, meaning the acquired company is active in two or more core therapeutic areas, none of which predominate.
Companies focused in generics ,companies with broad portfolios, and some specialty pharmaceutical companies, which focus their portfolios on drugs for clinical specialties or grow by merging with or acquiring other specialty pharmaceutical companies.
Our M&A advisory team focuses on identifying strategic fits for our clients and enabling them to grow their business through the inorganic route by making acquisitions that provide access to newer markets, better technologies and innovative products and result in creating shareholder value. Our scope of services includes the following:
- Identifying and Approaching potential clients and establishing a working relation with them
- Sourcing deals that make strategic sense to our clients
- Advising on Valuation and Documentation
- Transaction closure
- Post transaction support